rs121913151
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_000208.4(INSR):c.1195C>T(p.Arg399*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000137 in 1,461,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000208.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INSR | NM_000208.4 | c.1195C>T | p.Arg399* | stop_gained | Exon 5 of 22 | ENST00000302850.10 | NP_000199.2 | |
INSR | NM_001079817.3 | c.1195C>T | p.Arg399* | stop_gained | Exon 5 of 21 | NP_001073285.1 | ||
INSR | XM_011527988.3 | c.1195C>T | p.Arg399* | stop_gained | Exon 5 of 22 | XP_011526290.2 | ||
INSR | XM_011527989.4 | c.1195C>T | p.Arg399* | stop_gained | Exon 5 of 21 | XP_011526291.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INSR | ENST00000302850.10 | c.1195C>T | p.Arg399* | stop_gained | Exon 5 of 22 | 1 | NM_000208.4 | ENSP00000303830.4 | ||
INSR | ENST00000341500.9 | c.1195C>T | p.Arg399* | stop_gained | Exon 5 of 21 | 1 | ENSP00000342838.4 | |||
INSR | ENST00000598216.1 | n.1170C>T | non_coding_transcript_exon_variant | Exon 5 of 10 | 1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251448Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135900
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461846Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727234
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Leprechaunism syndrome Pathogenic:1
- -
not provided Uncertain:1
The R399X variant in the INSR gene has been reported previously in the heterozygous state, using alternate nomenclature R372X, in a patient with autosomal recessive severe insulin resistance for whom no second INSR variant was identified (Longo et al., 1992). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The variant is observed in 2/246216 alleles in large population cohorts (Lek et al., 2016). We interpret R399X as a variant of unknown significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at